Name:   Dr Ahlam Mohammed Omar Alhusaini 
E-mail:    aelhusaini@ksu.edu.sa
 
Qualifications:

• Bachelor degree in General Pharmacy, Pharmacy College, King Saud University 1995.
• Master degree in Toxicology, Pharmacology Department, Pharmacy College, King Saud University 2004.
• PhD degree in Pharmacology (Neuroscience), School of Pharmacy, Reading, United Kingdom 2016.

 
Prizes:

• Third prize, 2010 Grand Prize Micrograph Competition Finalists, Southampton, United Kingdom.
• Two distinction certificates from Saudi Cultural Bureau in United Kingdom (2014 and 2016).

 
Training:

• Training in Alsulymaniah Hospital for Children.
• Training in Military Hospital in Riyadh.
• Electrophysiology technique.
• Immunohistochemistry technique.
• Western blot technique.

Experience:

• Alyamamah Hospital in Riyadh, 1995 – 2006
  • In-patient pharmacy, out-patient pharmacy and emergency pharmacy.
  • Organizer of quality assurance of the pharmacy.
• Lecturer in Pharmacology Department – King Saud University, 2006 – 2016
• Assistant professor in Pharmacology Department – King Saud University, 2016 – Now.

 
Activities:

• Member in the Saudi Pharmaceutical Society.
• Member in the British Neuroscience Association (BNA).
• Attending some conferences and seminars organized by Saudi Pharmaceutical Society.
• Attending some conferences and seminars, United Kingdom (2011 – 2016).

 
Publications:
Poster publications
1.Peres, R. Hadid, N. Amada, C. Hill, A. Alhusaini, C.M. Williams, B.J. Whalley. (2013). The phytocannabinoid cannabidivarin demonstrates notable antiepileptic properties and is a genuine candidate for the treatment of temporal lobe epilepsy. Poster presentation at Society for Neuroscience Conference, San Diego, USA.
 
2.Alhusaini, C. Williams, B. Whalley. (2014). The Reduced Intensity Status Epilepticus (RISE) model of epileptogenesis and its characterisation on rat piriform cortex. Poster presentation at 7th Saudi Students Conference, Edinburgh, UK.
 
3.Alhusaini, B. Whalley. (2016). Initial electrophysiological characterisation of changes in epileptic olfactory cortex in the refined lithium-pilocarpine, murine model of spontaneous recurrent seizures. Poster presentation at 9th Saudi Students Conference, Birmingham, UK.
 
 
Journal publications
 
1.F.A. Iannotti, C.L. Hill, A. Leo, A. Alhusaini, C. Soubrane, E. Mazzarella, E, E. Russo, B.J. Whalley, V. Di Marzo, G.J. Stephens. The non-psychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chem Neurosci. 2014 Nov 19; 5(11):1131-41.
 
2.Alhusaini, C. Hill, I. Peres, R. Hadid, G.L. Woodhall, C.M.Williams, B.J.Whalley. The piriform cortex of reduced intensity status epilepticus-induced spontaneous recurrent seizure (RISE-SRS) model rats shares features consistent with human temporal lobe epilepsy. In preparation.